
Discover Lichen China Limited's transformative 6-K filing, detailing capital increases, name change, and shareholder approvals. Key insights into the company's strategic future.
Discover Lichen China Limited's transformative 6-K filing, detailing capital increases, name change, and shareholder approvals. Key insights into the company's strategic future.
Explore Golden Heaven Group Holdings Ltd.'s February 2025 6-K report detailing the EGM, share capital increase, and strategic consolidation plans to enhance growth and stability.
Explore Evaxion Biotech A/S's January 2025 Form 6-K filing revealing a DKK 11.47M share capital increase and warrant exercises. Key details on compliance and growth strategies.
Arqit Quantum Inc. reports on its EGM held on December 18, 2024, where shareholders approved a significant increase in authorized share capital, reflecting strong support for growth initiatives.
TORM plc's December 2024 Form 6-K reveals a capital increase via 7,468 Class A shares from RSU exercises. Details included in the December 18 press release.